<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Limited has submitted a compliance filing to BSE and NSE confirming that it does not qualify as a 'Large Corporate' under SEBI's framework as of March 31, 2025. As per SEBI circulars dated November 26, 2018 and October 19, 2023, companies with outstanding borrowings of Rs. 500 Crores or more are classified as Large Corporates and face additional debt-market borrowing obligations. The company's outstanding borrowing stood at Rs. 314.75 Crores as on March 31, 2025, which is well below the threshold. The company also disclosed its credit rating as 'CARE A; Stable' from CARE Ratings Limited. The letter is signed by the Company Secretary and Chief Financial Officer, Thirumalesh Tumma.
This is a routine regulatory compliance filing with no material impact on shareholders. By confirming it is not a Large Corporate, the company is not required to meet the mandatory incremental borrowing through debt securities (typically 25% of total borrowings), giving it more flexibility in how it raises funds.